Harvard Bioscience (HBIO) Divestments (2013 - 2023)

Harvard Bioscience (HBIO) posted quarterly Divestments of $512000.0 for Q1 2023, up 2944.44% quarter-over-quarter from -$18000.0 in Q4 2019.

Harvard Bioscience (HBIO) Divestments (2013 - 2023) Analysis & Trends

Harvard Bioscience (HBIO) has reported Divestments for 5 consecutive years, with $512000.0 the latest figure, recorded in Q1 2023.

In Q1 2023, Divestments changed N/A year-over-year to $512000.0; the TTM figure through Dec 2023 stood at $512000.0 (changed N/A YoY), while the FY2023 annual figure was $512000.0, changed N/A from the prior year.
Divestments rose to $512000.0 in Q1 2023 per HBIO's latest filing, from -$18000.0 in the prior quarter.
Across five years, Divestments topped out at $1.0 million in Q2 2019 and bottomed at -$18000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	-
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	13.00 Mn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	-
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	-
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	-
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	-
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	-
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	-
10	Harvard Bioscience	34.12 Mn	27.61 Mn	12.63 Mn	-

Download Data